Fenwick Represents Phil in its $25M Series B Financing

May 15, 2019


Fenwick & West represented Phil Inc., an end-to-end technology platform for distributing and managing specialty prescription drugs, in its $25M Series B financing led by new investor GreatPoint Ventures, with support from Tarsadia Investments, Crosslink Capital and Uncork Capital.​​​​​​

The funding will fuel company growth, with a focus on hiring technical talent and expanding geographic footprint. More information about Phil’s $25M Series B financing can be obtained from the company press release​.

The Fenwick transaction team was led by corporate lawyers Michael Esquivel, Stefano Quintini, Malcom Katz, Kyle Canchola and Benjamin Toussant.​​​​​​